Title: Inhibitex is a clinical-stage biopharmaceutical company.
Description: Engages in the discovery, development, and commercialization of new drugs that can prevent and treat serious infections caused by viruses, bacteria and fungi.
Keywords:Herpes zoster, shingles, post-herpetic neuralgia, PHN, FV-100, Staphylococcus aureus, MRSA, , , cytomegalovirus, CMV, HIV, AIDS, HCV, hepatitis C, biopharmaceutical, infections, viruses, and bacteria.
